Correlation Between C Rad and Xvivo Perfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C Rad and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C Rad and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C Rad AB and Xvivo Perfusion AB, you can compare the effects of market volatilities on C Rad and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C Rad with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of C Rad and Xvivo Perfusion.

Diversification Opportunities for C Rad and Xvivo Perfusion

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between CRAD-B and Xvivo is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding C Rad AB and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and C Rad is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C Rad AB are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of C Rad i.e., C Rad and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between C Rad and Xvivo Perfusion

Assuming the 90 days trading horizon C Rad AB is expected to generate 0.84 times more return on investment than Xvivo Perfusion. However, C Rad AB is 1.2 times less risky than Xvivo Perfusion. It trades about 0.13 of its potential returns per unit of risk. Xvivo Perfusion AB is currently generating about 0.02 per unit of risk. If you would invest  2,855  in C Rad AB on September 24, 2024 and sell it today you would earn a total of  120.00  from holding C Rad AB or generate 4.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

C Rad AB  vs.  Xvivo Perfusion AB

 Performance 
       Timeline  
C Rad AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C Rad AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Xvivo Perfusion AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Xvivo Perfusion is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

C Rad and Xvivo Perfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C Rad and Xvivo Perfusion

The main advantage of trading using opposite C Rad and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C Rad position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.
The idea behind C Rad AB and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings